Reassuringly, performance of the BioMedomics COVID-19 IgG/IgM Rapid Antibody Test at the POC was congruent with its analytic sensitivity and matched previous laboratory assessments of its performance.17 The gene discussed is CD40LG; the disease is COVID-19.